Clinical efficacy of lenalidomide in fludarabine-refractory chronic lymphocytic leukemia patients.

被引：4
|
作者：
Chanan-Khan, AsherA. [1 ]
Czuczman, Myron S. [1 ]
Padmanabhan, Swarminathan [1 ]
Keating, Michael J. [2 ]
O'Brien, Susan M. [2 ]
Wierda, William G. [2 ]
Ferrajoli, Alessandra [2 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY USA
[2] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.3108.3108
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3108
引用
收藏
页码：914A / 914A
页数：1
相关论文
共 50 条
  • [1] Treatment of Fludarabine-refractory Chronic Lymphocytic Leukemia
    Tsimberidou, Apostolia-Maria
    Keating, Michael J.
    CANCER, 2009, 115 (13) : 2824 - 2836
  • [2] Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
    Gritti, Giuseppe
    Reda, Gianluigi
    Maura, Francesco
    Piciocchi, Alfonso
    Baldini, Luca
    Molica, Stefano
    Neri, Antonino
    Cortelezzi, Agostino
    LEUKEMIA & LYMPHOMA, 2012, 53 (03) : 424 - 429
  • [3] Efficacy and Safety of Ofatumumab in Patients with Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (03): : 200 - 202
  • [4] R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia
    Tonino, S. H.
    van Gelder, M.
    Eldering, E.
    van Oers, M. H.
    Kater, A. P.
    LEUKEMIA, 2010, 24 (03) : 652 - 654
  • [5] Treatment of patients with fludarabine-refractory chronic lymphocytic leukemia: need for new treatment options
    Tsimberidou, Apostolia-Maria
    Keating, Michael J.
    LEUKEMIA & LYMPHOMA, 2010, 51 (07) : 1188 - 1199
  • [6] Phase II Trial of Subcutaneous Alemtuzumab in Patients with Fludarabine-Refractory Chronic Lymphocytic Leukemia
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (03): : 202 - 203
  • [7] Azacitidine in Fludarabine-Refractory Chronic Lymphocytic Leukemia: A Phase II Study
    Malik, Asifa
    Shoulder, Mahran
    Garcia-Manero, Guillermo
    Wierda, William
    Cortes, Jorge
    Bickel, Susan
    Keating, Michael J.
    Estrov, Zeev
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (03): : 292 - 295
  • [8] R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia
    S H Tonino
    M van Gelder
    E Eldering
    M H van Oers
    A P Kater
    Leukemia, 2010, 24 : 652 - 654
  • [9] Pilot experience with continuous infusion alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia
    Ferrajoli, Alessandra
    Wierda, William G.
    LaPushin, Ruth
    O'Brien, Susan M.
    Faderl, Stefan
    Browning, Mary L.
    Keating, Michael J.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (04) : 296 - 298
  • [10] Diphtheria fusion protein ONTAK® therapy of patients with fludarabine-refractory chronic lymphocytic leukemia.
    Frankel, A
    Fleming, D
    Gartenhaus, R
    Powell, BL
    Black, JH
    Leftwich, CF
    BLOOD, 2002, 100 (11) : 365B - 366B
12345